Steward Partners Investment Advisory’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

Steward Partners Investment Advisory’s Portfolio QNTM Stock Details QNTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$101K	Buy	27,881 +23,500	+536%	+$111K	﹤0.01%	2582
2026 Q1	$21.2K	Hold	4,381	–	–	﹤0.01%	3204
2025 Q4	$32K	Buy	4,381 +1,281	+41%	+$14K	﹤0.01%	2910
2025 Q3	$50.8K	Hold	3,100	–	–	﹤0.01%	2605
2025 Q2	$79.8K	Buy	+3,100	New	+$38.2K	﹤0.01%	2239
2021 Q2	–	Sell	-46	Closed	-$5.73K	–	7447
2021 Q1	$5.73K	Buy	+46	New	+$6.43K	﹤0.01%	2981

Other funds holding QNTM

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

PTP

Platform Technology Partners New York $611M AUM 25.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return

NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

GRP

Global Retirement Partners San Rafael, California $6.54B AUM

Steward Partners Investment Advisory's QNTM Position: Q2 2026 in Review

Steward Partners Investment Advisory increased its Quantum Biopharma Class B Subordinate Voting Shares (QNTM) stake by 536% in Q2 2026, buying an estimated $111K and bringing the position to 27,881 shares worth $101K. The position accounts for ﹤0.01% of the portfolio, ranked #2582.

Steward Partners Investment Advisory first reported a position in QNTM in Q1 2021 and has held it in 6 quarters since. 26 funds tracked by Wall St. Rank hold QNTM as of Q2 2026.

Steward Partners Investment Advisory held 27,881 shares of Quantum Biopharma Class B Subordinate Voting Shares worth $101K as of Q2 2026.
Steward Partners Investment Advisory bought 23,500 Quantum Biopharma Class B Subordinate Voting Shares shares in Q2 2026, an estimated $111K.
Quantum Biopharma Class B Subordinate Voting Shares made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #2582 holding.
Steward Partners Investment Advisory first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q1 2021 and has held it in 6 quarters since.
26 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.